Acute myocardial infarction therapy: in vitro and in vivo evaluation of atrial natriuretic peptide and triphenylphosphonium dual ligands modified, baicalin-loaded nanoparticulate system

References

• Dong Z, Guo J, Xing X, et al. (2017). RGD modified and PEGylated lipid nanoparticles loaded with puerarin: formulation, characterization and protective effects on acute myocardial ischemia model. Biomed Pharmacother 89:297–304.
   PubMed Web of Science ®Google Scholar
• Ferreira MPA, Ranjan S, Kinnunen S, et al. (2017). Drug-loaded multifunctional nanoparticles targeted to the endocardial layer of the injured heart modulate hypertrophic signaling. Small 13:1701276.
   Web of Science ®Google Scholar
• Formiga FR, Garbayo E, Díaz-Herráez P, et al. (2013). Biodegradation and heart retention of polymeric microparticles in a rat model of myocardial ischemia. Eur J Pharm Biopharm 85:665–72.
   PubMed Web of Science ®Google Scholar
• Fu Q, Wang J, Liu H. (2020). Chemo-immune synergetic therapy of esophageal carcinoma: trastuzumab modified, cisplatin and fluorouracil co-delivered lipid–polymer hybrid nanoparticles. Drug Deliv 27:1535–43.
   PubMed Web of Science ®Google Scholar
• Gaudin A, Yemisci M, Eroglu H, et al. (2014). Squalenoyl adenosine nanoparticles provide neuroprotection after stroke and spinal cord injury. Nat Nanotechnol 9:1054–62.
   PubMed Web of Science ®Google Scholar
• Guo J, Xing X, Lv N, et al. (2019). Therapy for myocardial infarction: in vitro and in vivo evaluation of puerarin-prodrug and tanshinone co-loaded lipid nanoparticulate system. Biomed Pharmacother 120:109480.
   PubMed Web of Science ®Google Scholar
• Hao J, Tong T, Jin K, et al. (2017). Folic acid-functionalized drug delivery platform of resveratrol based on Pluronic 127/d-α-tocopheryl polyethylene glycol 1000 succinate mixed micelles. Int J Nanomedicine 12:2279–92.
   PubMed Web of Science ®Google Scholar
• Higuchi A, Ku NJ, Tseng YC, et al. (2017). Stem cell therapies for myocardial infarction in clinical trials: bioengineering and biomaterial aspects. Lab Invest 97:1167–79.
   PubMed Web of Science ®Google Scholar
• Izadifar M, Kelly ME, Chen X. (2016). Regulation of sequential release of growth factors using bilayer polymeric nanoparticles for cardiac tissue engineering. Nanomedicine 11:3237–59.
   PubMed Web of Science ®Google Scholar
• Jiang T, Ma S, Shen Y, et al. (2021). Topical anesthetic and pain relief using penetration enhancer and transcriptional transactivator peptide multi-decorated nanostructured lipid carriers. Drug Deliv 28:478–86.
   PubMed Web of Science ®Google Scholar
• Jin Y, Wang Y, Liu X, et al. (2020). Synergistic combination chemotherapy of lung cancer: cisplatin and doxorubicin conjugated prodrug loaded, glutathione and pH sensitive nanocarriers. Drug Des Devel Ther 14:5205–15.
   PubMed Web of Science ®Google Scholar
• Kim DY, Kim HS, Le UN, et al. (2012). Evaluation of a mitochondrial voltage sensor, (18F-fluoropentyl)triphenylphosphonium cation, in a rat myocardial infarction model. J Nucl Med 53:1779–85.
   PubMed Web of Science ®Google Scholar
• Li M, Feng S, Xing H, Sun Y. (2020). Dexmedetomidine and levobupivacaine co-loaded, transcriptional transactivator peptide modified nanostructured lipid carriers or lipid–polymer hybrid nanoparticles, which performed better for local anesthetic therapy? Drug Deliv 27:1452–60.
   PubMed Web of Science ®Google Scholar
• Lu G, Cao L, Zhu C, et al. (2019). Improving lung cancer treatment: hyaluronic acid‑modified and glutathione‑responsive amphiphilic TPGS‑doxorubicin prodrug‑entrapped nanoparticles. Oncol Rep 42:361–9.
   PubMed Web of Science ®Google Scholar
• Lu L, Liu M, Sun R, et al. (2015). Myocardial infarction: symptoms and treatments. Cell Biochem Biophys 72:865–7.
   PubMed Web of Science ®Google Scholar
• Lukyanov AN, Hartner WC, Torchilin VP. (2004). Increased accumulation of PEG-PE micelles in the area of experimental myocardial infarction in rabbits. J Control Release 94:187–93.
   PubMed Web of Science ®Google Scholar
• Mueller C, McDonald K, de Boer RA, et al. (2019). Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations. Eur J Heart Fail 21:715–31.
   PubMed Web of Science ®Google Scholar
• Nakano Y, Matoba T, Tokutome M, et al. (2016). Nanoparticle-mediated delivery of irbesartan induces cardioprotection from myocardial ischemia-reperfusion injury by antagonizing monocyte-mediated inflammation. Sci Rep 6:29601.
   PubMed Web of Science ®Google Scholar
• Ong SB, Lu S, Katwadi K, et al. (2017). Nanoparticle delivery of mitoprotective agents to target ischemic heart disease. Future Cardiol 13:195–8.
   PubMed Web of Science ®Google Scholar
• Qiu J, Cai G, Liu X, Ma D. (2017). αvβ3 integrin receptor specific peptide modified, salvianolic acid B and panax notoginsenoside loaded nanomedicine for the combination therapy of acute myocardial ischemia. Biomed Pharmacother 96:1418–26.
   PubMed Web of Science ®Google Scholar
• Ruckenstein E, Li ZF. (2005). Surface modification and functionalization through the self-assembled monolayer and graft polymerization. Adv Colloid Interface Sci 113:43–63.
   PubMed Web of Science ®Google Scholar
• Shao M, Yang W, Han G. (2017). Protective effects on myocardial infarction model: delivery of schisandrin B using matrix metalloproteinase-sensitive peptide-modified, PEGylated lipid nanoparticles. Int J Nanomedicine 12:7121–30.
   PubMed Web of Science ®Google Scholar
• Shao Y, Luo W, Guo Q, et al. (2019). In vitro and in vivo effect of hyaluronic acid modified, doxorubicin and gallic acid co-delivered lipid–polymeric hybrid nano-system for leukemia therapy. Drug Des Devel Ther 13:2043–55.
   PubMed Web of Science ®Google Scholar
• Shi ZY, Liu Y, Dong L, et al. (2017). Cortistatin improves cardiac function after acute myocardial infarction in rats by suppressing myocardial apoptosis and endoplasmic reticulum stress. J Cardiovasc Pharmacol Ther 22:83–93.
   PubMed Web of Science ®Google Scholar
• Sun G, Lin X, Hong Y, et al. (2012). PEGylation for drug delivery to ischemic myocardium: pharmacokinetics and cardiac distribution of poly(ethylene glycol)s in mice with normal and ischemic myocardium. Eur J Pharm Sci 46:545–52.
   PubMed Web of Science ®Google Scholar
• Valle Raleigh J, Mauro AG, Devarakonda T, et al. (2017). Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia/reperfusion injury via eNOS-dependent mechanism. Cardiovasc Res 113:609–19.
   PubMed Web of Science ®Google Scholar
• Wang G, Wang Z, Li C, et al. (2018). RGD peptide-modified, paclitaxel prodrug-based, dual-drugs loaded, and redox-sensitive lipid–polymer nanoparticles for the enhanced lung cancer therapy. Biomed Pharmacother 106:275–84.
   PubMed Web of Science ®Google Scholar
• Wang J, Su G, Yin X, et al. (2019). Non-small cell lung cancer-targeted, redox-sensitive lipid–polymer hybrid nanoparticles for the delivery of a second-generation irreversible epidermal growth factor inhibitor-afatinib: in vitro and in vivo evaluation. Biomed Pharmacother 120:109493.
   PubMed Web of Science ®Google Scholar
• Wang X, He F, Liao Y, et al. (2013). Baicalin pretreatment protects against myocardial ischemia/reperfusion injury by inhibiting mitochondrial damage-mediated apoptosis. Int J Cardiol 168:4343–5.
   PubMed Web of Science ®Google Scholar
• Yao C, Shi X, Lin X, et al. (2015). Increased cardiac distribution of mono-PEGylated Radix Ophiopogonis polysaccharide in both myocardial infarction and ischemia/reperfusion rats. Int J Nanomedicine 10:409–18.
   PubMed Web of Science ®Google Scholar
• Yu J, Du KT, Fang Q, et al. (2010). The use of human mesenchymal stem cells encapsulated in RGD modified alginate microspheres in the repair of myocardial infarction in the rat. Biomaterials 31:7012–20.
   PubMed Web of Science ®Google Scholar
• Yu J, Li W, Yu D. (2018). Atrial natriuretic peptide modified oleate adenosine prodrug lipid nanocarriers for the treatment of myocardial infarction: in vitro and in vivo evaluation. Drug Des Devel Ther 12:1697–706.
   PubMed Web of Science ®Google Scholar
• Zhang J, Xiao X, Zhu J, et al. (2018). Lactoferrin- and RGD-comodified, temozolomide and vincristine-coloaded nanostructured lipid carriers for gliomatosis cerebri combination therapy. Int J Nanomedicine 13:3039–51.
   PubMed Web of Science ®Google Scholar
• Zhang S, Li J, Hu S, et al. (2018). Triphenylphosphonium and d-α-tocopheryl polyethylene glycol 1000 succinate-modified, tanshinone IIA-loaded lipid–polymeric nanocarriers for the targeted therapy of myocardial infarction. Int J Nanomedicine 13:4045–57.
   PubMed Web of Science ®Google Scholar
• Zhang S, Wang J, Pan J. (2016). Baicalin-loaded PEGylated lipid nanoparticles: characterization, pharmacokinetics, and protective effects on acute myocardial ischemia in rats. Drug Deliv 23:3696–703.
   PubMed Web of Science ®Google Scholar
• Zheng G, Zheng M, Yang B, et al. (2019). Improving breast cancer therapy using doxorubicin loaded solid lipid nanoparticles: synthesis of a novel arginine-glycine-aspartic tripeptide conjugated, pH sensitive lipid and evaluation of the nanomedicine in vitro and in vivo. Biomed Pharmacother 116:109006.
   PubMed Web of Science ®Google Scholar
• Zuurbier CJ, Bertrand L, Beauloye CR, et al. (2020). Cardiac metabolism as a driver and therapeutic target of myocardial infarction. J Cell Mol Med 24:5937–54.
   PubMed Web of Science ®Google Scholar